Medicure Inc. (CVE:MPH – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of C$1.22 and traded as high as C$1.23. Medicure shares last traded at C$1.23, with a volume of 200 shares.
Medicure Price Performance
The company has a current ratio of 2.03, a quick ratio of 1.29 and a debt-to-equity ratio of 4.65. The stock has a fifty day simple moving average of C$1.22 and a two-hundred day simple moving average of C$1.16. The company has a market cap of C$12.84 million, a PE ratio of -3.73 and a beta of 0.91.
About Medicure
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications.
See Also
- Five stocks we like better than Medicure
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Your Signature Is Missing – Act Before It’s Too Late
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
